Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 30 Jan 2025

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators

in Multiple Sclerosis and Neuroimmunology

Michael Hecker
Brit Fitzner
Isis Ludwig-Portugall
Friederike Bohne
Edmar Heyland
Juliane Klehmet
Matthias Grothe
Matthias Schwab
Alexander Winkelmann
Stefanie Meister

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531447

1,452 views

Review

Published on 29 Jan 2025

Immune conversations at the border: meningeal immunity in health and disease

in Multiple Sclerosis and Neuroimmunology

Preya U. Patel
Aryan Regmi
Angelina I. Dass
Olga L. Rojas

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531068

1,190 views

Review

Published on 28 Jan 2025

Neutrophils, NETs and multiple sclerosis: a mini review

in Multiple Sclerosis and Neuroimmunology

Moyuan Quan
Huining Zhang
Xiaohong Deng
Huijia Liu
Yanqiu Xu
Xiujuan Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1487814

1,635 views
1 citation

Review

Published on 27 Jan 2025

The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review

in Multiple Sclerosis and Neuroimmunology

Julie J. Paik
Lisa Christopher-Stine
Mikael Boesen
John A. Carrino
S. Peter Eggleton
Deborah Denis
Olga Kubassova

Frontiers in Immunology

doi 10.3389/fimmu.2025.1455867

1,874 views

Case Report

Published on 24 Jan 2025

Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review

in Multiple Sclerosis and Neuroimmunology

Xuan Wu
Xiao-tian Xu
Lin Zhou
Kai Qiao
Chong-bo Zhao
Su-shan Luo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1498847

1,917 views

Original Research

Published on 24 Jan 2025

Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension

in Multiple Sclerosis and Neuroimmunology

Yuyu Li
Mingming Sun
Xintong Xu
Biyue Chen
Xiyun Chen
Yuhang Wang
Quangang Xu
Huanfen Zhou
Shihui Wei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516909

904 views

Original Research

Published on 23 Jan 2025

The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system

in Multiple Sclerosis and Neuroimmunology

Yue Zhou
Yutong Wu
Xiao Zhao
Lingxu Xu
Mingguang Sun
Zhaoyou Meng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1515730

2,005 views

Original Research

Published on 22 Jan 2025

Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review

in Multiple Sclerosis and Neuroimmunology

Runhua Bai
Li An
Wei Du
Zhiwei Wang
Xiaokun Qi
Jianguo Liu
Ming Ren
Yingxin Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519700

1,875 views

Case Report

Published on 17 Jan 2025

Severe Guillain-Barré syndrome with concurrent optic neuritis in a pediatric patient: a case report

in Multiple Sclerosis and Neuroimmunology

Xin Xue
Yingcun Bao
Yakun Yu
Qun Li
Mei Liu
Xiaoling Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1517943

1,301 views
1 citation

Systematic Review

Published on 17 Jan 2025

Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Matteo Paolucci
Andrea Zini
Luana Morelli
Rocco Liguori
Maria Pia Giannoccaro

Frontiers in Immunology

doi 10.3389/fimmu.2025.1491880

1,001 views

Original Research

Published on 14 Jan 2025

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

J. Q. Alida Chen
Dennis D. Wever
Niamh B. McNamara
Morjana Bourik
Joost Smolders
Jörg Hamann
Inge Huitinga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522381

2,020 views
1 citation

Case Report

Published on 14 Jan 2025

Case report: Overlapping syndrome of MOG-IgG associated optic neuritis and autoimmune encephalitis with co-existence of anti-NMDAR and anti-GABABR antibodies

in Multiple Sclerosis and Neuroimmunology

Zhujun Mei
Jingguo Wang
Junling Wang
Xiaoni Liu
Bo Deng
Wenbo Yang
Xiang Zhang
Xiangjun Chen
Hai Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461024

1,141 views

Case Report

Published on 13 Jan 2025

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases

in Multiple Sclerosis and Neuroimmunology

Tianying Ma
Ying Zhu
Ruixia Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497398

1,409 views
1 citation

Case Report

Published on 10 Jan 2025

Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G–seropositive neuromyelitis optica spectrum disorder: a case series report

in Multiple Sclerosis and Neuroimmunology

Hesham Abboud
Adnan Subei
Buse Sengul
Robert K. Shin
Paige Goulette
Rosemarie Walch
Jeanie Coté
Robert Pace
Ahmed Z. Obeidat
Lisa Ferayorni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1526563

1,733 views
1 citation

Original Research

Published on 09 Jan 2025

Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression

in Multiple Sclerosis and Neuroimmunology

Stefano Ruberto
María I. Domınguez-Mozo
M. Angel Garcıa-Martınez
Davide Cossu
Leonardo A. Sechi
Roberto Alvarez-Lafuente

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505239

1,427 views
2 citations

Mini Review

Published on 09 Jan 2025

Spatial distribution-based progression of spinal cord injury pathology: a key role for neuroimmune cells

in Multiple Sclerosis and Neuroimmunology

Jian Li
Xiaolei Zhai
Chaochun Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505755

940 views